Elevian Overview

  • Founded
  • 2017
Founded
  • Status
  • Private
  • Employees
  • 20
Employees
  • Latest Deal Type
  • Seed
  • Latest Deal Amount
  • $15.3M
Latest Deal Amount
  • Investors
  • 9

Elevian General Information

Description

Developer of regenerative medicines designed to halt and reverse the molecular damage caused by aging. The company's medicine identifies blood factors that regulate aging and stimulate the body's natural repair and regeneration mechanisms, enabling users to prevent and treat age-related diseases.

Contact Information

Website
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Drug Discovery
Other Industries
Pharmaceuticals
Biotechnology
Primary Office
  • 212 Hedge Road
  • Menlo Park, CA 94025
  • United States
+1 (650) 000-0000

Elevian Timeline

201820192020
Financing RoundCaptured Employee CountEstimated Employee Growth
Want detailed data on 2M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Elevian Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
3. Seed Round 21-Jul-2020 $15.3M 000.00 000.00 Completed Generating Revenue
2. Early Stage VC (Series A) 20-Feb-2018 00.00 00.00 Completed Generating Revenue
1. Seed Round 20-Oct-2017 $2.6M $2.6M Completed Generating Revenue
To view Elevian’s complete valuation and funding history, request access »

Elevian Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate ($) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Seed-3 0,000,000 00.000000 00.00 00.00 00.00 00 00.00 00.000
Seed-2 0,000,000 00.000000 00.00 00.00 00.00 00 00.00 0.000
Seed-1 2,108,743 $0.000100 $0.1 $1.24 $1.24 1x $1.24 11.83%
Seed 2,654,866 $0.000100 $0.18 $2.26 $2.26 1x $2.26 14.67%
To view Elevian’s complete cap table history, request access »

Elevian Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last Financing Details
Developer of regenerative medicines designed to halt and reverse the molecular damage caused by aging. The company's med
Drug Discovery
Menlo Park, CA
20 As of 2018
000.00
00.00 0000-00-00
000000000 000.00

0000000

. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo c
0000000000000
San Diego, CA
000 As of 0000
00000
000000000 - 00000

00000 00

eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud e
0000000000000
Brisbane, CA
000 As of 0000
00000
000000 - 000 00000
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Elevian Competitors (3)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Samumed Private Equity-Backed San Diego, CA 000 00000 000000000 - 00000
00000 000000000000 Formerly VC-backed Brisbane, CA 000 00000 000000 - 000 00000
000000 Corporate Backed or Acquired Pasadena, CA 00 000.00 000000000 000.00
To view Elevian’s complete competitors history, request access »

Elevian Executive Team (9)

Name Title Board Seat Contact Info
Mark Allen MD Co-Founder, Chief Executive Officer & Board Member
Brock Reeve Co-Founder & Board Member
Amy Wagers Ph.D Scientific Co-Founder
Lee Rubin Ph.D Scientific Co-Founder
Ryan Walker Ph.D Scientific Co-Founder
You’re viewing 5 of 9 executive team members. Get the full list »

Elevian Board Members (8)

Name Representing Role Since
Brock Reeve Elevian Co-Founder & Board Member 000 0000
Daniel Marshak Ph.D Self Board Member 000 0000
James Larrick MD Self Board Member 000 0000
Luis Alvarez Ph.D Elevian Co-Founder, Head of Organ Manufacturing & Board Member 000 0000
Mark Allen MD Elevian Co-Founder, Chief Executive Officer & Board Member 000 0000
You’re viewing 5 of 8 board members. Get the full list »

Elevian Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Elevian Investors (9)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
For Good Ventures Venture Capital Minority 000 0000 000000 0
Formic Ventures Venture Capital Minority 000 0000 000000 0
Lauder Partners Venture Capital Minority 000 0000 000000 0
Thynk Capital Venture Capital Minority 000 0000 000000 0
Bold Capital Partners Venture Capital Minority 000 0000 000000 0
You’re viewing 5 of 9 investors. Get the full list »